Technology transfer perspectives in globalising India (drugs and pharmaceuticals and biotechnology) |
| |
Authors: | S P Agarwal Ashwani Gupta R Dayal |
| |
Institution: | (1) Centre for International Trade in Technology, Indian Institute of Foreign Trade, New Delhi, India;(2) Technology Transfer, DSIR, Ministry of Science & Technology, New Delhi, India |
| |
Abstract: | The paper briefly outlines the status of technology transfer related issues in drugs & pharma and biotechnology sectors in
India. The paper also outlines the contemporary business strategies including R&D and technology transfer models. The study
indicates that present technology transfer policies and mechanisms are weak and need to be restructured. The current fiscal
incentives and tax concessions etc. available for R&D in industry seem to have outlived and are no longer attractive because
of continuous lowering of tariff rates and tax rates in the context of WTO and liberalization of policies. Moreover, the issue
of R&D support to industry is not covered in the WTO as in case of subsidies. Therefore, it is advisable for the government
to revisit the existing promotional measures for R&D. FDI policies also need to be tailored to encourage Technology transfers
and capability building. Recommendations are made for making Technology Transfer more effective for the growth and competitiveness
of the industry. A technology transfer management model is suggested.
|
| |
Keywords: | Technology R& D Drugs & pharma Biotechnology Competitiveness Policy WTO Incentives Globalization Model Technology transfer |
本文献已被 SpringerLink 等数据库收录! |